Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Autran

Showing results (101-110 of 201) with videos related to

Pageof 21
Sort By:
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
The Journal of Infectious Diseases|May 18, 2005
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogressionValérie Martinez, Dominique Costagliola, Olivia Bonduelle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humansAnnika Vogt, Brice Mahé, Dominique Costagliola, et al.
AIDS (London, England)|March 28, 2003
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopeniaGuislaine Carcelain, Pierre Saint-Mézard, Hester Korthals Altes, et al.
AIDS (London, England)|August 31, 2010
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus controlJing Xie, Wei Lu, Assia Samri, et al.
Cytometry. Part B, Clinical Cytometry|September 27, 2005
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settingsSilva Barbesti, Laura Soldini, Guisline Carcelain, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Blood|October 31, 2002
Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and ageMarion Malphettes, Guislaine Carcelain, Pierre Saint-Mezard, et al.
AIDS (London, England)|July 21, 2009
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cellsCamille Lécuroux, Isabelle Girault, François Boutboul, et al.
AIDS (London, England)|December 22, 2021
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adultsChristine Durier, Séverine Mercier-Delarue, Nathalie Colin De Verdière, et al.
Pageof 21

Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
The Journal of Infectious Diseases|May 18, 2005
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogressionValérie Martinez, Dominique Costagliola, Olivia Bonduelle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humansAnnika Vogt, Brice Mahé, Dominique Costagliola, et al.
AIDS (London, England)|March 28, 2003
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopeniaGuislaine Carcelain, Pierre Saint-Mézard, Hester Korthals Altes, et al.
AIDS (London, England)|August 31, 2010
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus controlJing Xie, Wei Lu, Assia Samri, et al.
Cytometry. Part B, Clinical Cytometry|September 27, 2005
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settingsSilva Barbesti, Laura Soldini, Guisline Carcelain, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Blood|October 31, 2002
Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and ageMarion Malphettes, Guislaine Carcelain, Pierre Saint-Mezard, et al.
AIDS (London, England)|July 21, 2009
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cellsCamille Lécuroux, Isabelle Girault, François Boutboul, et al.
AIDS (London, England)|December 22, 2021
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adultsChristine Durier, Séverine Mercier-Delarue, Nathalie Colin De Verdière, et al.
Pageof 21